Pacer Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-207
| Closed | -$58K | – | 2611 |
|
|
2024
Q2 | $58K | Buy |
207
+37
| +22% | +$10.4K | ﹤0.01% | 3024 |
|
|
2024
Q1 | $45.4K | Buy |
+170
| New | +$45.4K | ﹤0.01% | 3207 |
|
|
2021
Q2 | – | Sell |
-656
| Closed | -$77K | – | 1491 |
|
|
2021
Q1 | $77K | Sell |
656
-330
| -33% | -$38.7K | ﹤0.01% | 1333 |
|
|
2020
Q4 | $110K | Buy |
986
+150
| +18% | +$16.7K | ﹤0.01% | 1354 |
|
|
2020
Q3 | $99K | Buy |
+836
| New | +$99K | ﹤0.01% | 1250 |
|
|
2018
Q4 | – | Sell |
-1,078
| Closed | -$231K | – | 842 |
|
|
2018
Q3 | $231K | Buy |
+1,078
| New | +$231K | 0.01% | 1002 |
|